Trials / Completed
CompletedNCT00484809
Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
A Post-Marketing Surveillance Looking at Safety of Enbrel (Etanercept) in Adults With Active Rheumatoid Arthritis (RA) and Children With Juvenile Rheumatoid Arthritis (JRA).
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
This postmarketing surveillance study will evaluate the safety profile of Enbrel (etanercept) in an Indian population. It will provide surveillance on a currently approved indication for Enbrel of reducing symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enbrel (Etanercept) |
Timeline
- Start date
- 2004-03-01
- Completion
- 2006-02-01
- First posted
- 2007-06-11
- Last updated
- 2007-12-14
Source: ClinicalTrials.gov record NCT00484809. Inclusion in this directory is not an endorsement.